Table 2

Comparison of current study results to other published series in the literature

Turri-Zanoni et al20Zhang et al21Broderick et al22Angel et al23Chao et al29Floyd et al24Current study
Study period2/24–3/151/23–4/63/10–4/154/1–4/303/1–6/30
Study locationVarese, ItalyWuhan, ChinaManchester, UKNew York, USAPhiladelphia, USANew York, USADenver/Aurora, USA
Number of patients32111098533826
Time from intubation to tracheostomy in days (mean±SD or (range))15 (9–21)17 (6–36)17±511±520±724 (20–28)25±5
Percutaneous10 (31%)6 (55%)098 (100%)*19 (55%)026 (100%)
Complications
 Bleeding0005 (5%)1 (2%)4 (11%)2 (8%)
 Wound infection02 (18%)01 (2%)00
Follow-up after tracheostomy in days (mean±SD or (range)))21 (8–37)14±711±649±23
Ventilator support at discharge or follow-up, n (%)
 Full support1 (10%)40 (41%)3 (12%)
 Partial support2 (20%)19 (19%)2 (8%)
 No ventilatory support9 (82%)7 (70%)32 (33%)30 (57%)21 (55%)21 (81%)
Time to liberation from ventilator (mean±SD or (range))7 (2–19)12±7109±6
Tracheostomy status, n (%)
 Downsized19 (19%)14 (26%)7 (18%)18 (73%)
 Decannulated1 (3%)6 (60%)8 (8%)7 (13%)16 (65%)
Time to decannulation
(mean±SD)
10±417±51420±10
Disposition
 Deceased5 (16%)007 (7%)6 (11%)2 (5%)4 (15%)
 ICU4 (40%)76 (78%)0
 Non-critical care4 (40%)11 (11%)0
 Discharged2 (20%)4 (4%)16 (30%)22 (85%)
  • *Majority performed using a “novel” percutaneous dilation technique.

  • ICU, intensive care unit.